Free Trial

Smart for Life (SMFL) Competitors

Smart for Life logo
$0.0023 -0.02 (-90.50%)
As of 07/28/2025 03:44 PM Eastern

SMFL vs. SYRS, VIRX, NCNA, CAPS, VINC, BON, MYMD, UPC, VRPX, and SCPS

Should you be buying Smart for Life stock or one of its competitors? The main competitors of Smart for Life include Syros Pharmaceuticals (SYRS), Viracta Therapeutics (VIRX), NuCana (NCNA), Capstone Therapeutics (CAPS), Vincerx Pharma (VINC), Bon Natural Life (BON), MyMD Pharmaceuticals (MYMD), Universe Pharmaceuticals (UPC), Virpax Pharmaceuticals (VRPX), and Scopus BioPharma (SCPS). These companies are all part of the "pharmaceutical products" industry.

Smart for Life vs. Its Competitors

Smart for Life (NASDAQ:SMFL) and Syros Pharmaceuticals (NASDAQ:SYRS) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, profitability, risk, dividends, institutional ownership, earnings, valuation and analyst recommendations.

Smart for Life has a beta of 17.24, suggesting that its share price is 1,624% more volatile than the S&P 500. Comparatively, Syros Pharmaceuticals has a beta of 1.31, suggesting that its share price is 31% more volatile than the S&P 500.

Syros Pharmaceuticals has a consensus price target of $3.33, suggesting a potential upside of 302,930.30%. Given Syros Pharmaceuticals' stronger consensus rating and higher probable upside, analysts clearly believe Syros Pharmaceuticals is more favorable than Smart for Life.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Smart for Life
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Syros Pharmaceuticals
0 Sell rating(s)
4 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.20

Smart for Life's return on equity of 0.00% beat Syros Pharmaceuticals' return on equity.

Company Net Margins Return on Equity Return on Assets
Smart for LifeN/A N/A N/A
Syros Pharmaceuticals N/A -3,369.56%-97.04%

Smart for Life has higher revenue and earnings than Syros Pharmaceuticals.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Smart for Life$11.11M0.00-$22.68MN/AN/A
Syros Pharmaceuticals$386K0.08-$164.57M-$3.030.00

In the previous week, Syros Pharmaceuticals had 1 more articles in the media than Smart for Life. MarketBeat recorded 1 mentions for Syros Pharmaceuticals and 0 mentions for Smart for Life. Smart for Life's average media sentiment score of 0.00 equaled Syros Pharmaceuticals'average media sentiment score.

Company Overall Sentiment
Smart for Life Neutral
Syros Pharmaceuticals Neutral

28.4% of Smart for Life shares are held by institutional investors. Comparatively, 91.5% of Syros Pharmaceuticals shares are held by institutional investors. 31.7% of Smart for Life shares are held by insiders. Comparatively, 12.3% of Syros Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Summary

Smart for Life and Syros Pharmaceuticals tied by winning 6 of the 12 factors compared between the two stocks.

Get Smart for Life News Delivered to You Automatically

Sign up to receive the latest news and ratings for SMFL and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SMFL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SMFL vs. The Competition

MetricSmart for LifeMedicinals & botanicals IndustryMedical SectorNASDAQ Exchange
Market Cap$16K$3.44B$5.70B$9.56B
Dividend YieldN/AN/A4.71%4.06%
P/E RatioN/A7.6328.1919.94
Price / Sales0.0027.08461.9396.03
Price / CashN/A5.6236.3258.72
Price / Book0.001.118.295.77
Net Income-$22.68M$17.44M$3.25B$259.21M
7 Day PerformanceN/A-0.80%0.21%-0.80%
1 Month PerformanceN/A6.30%8.71%9.81%
1 Year PerformanceN/A-29.22%32.76%14.37%

Smart for Life Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SMFL
Smart for Life
N/A$0.00
-90.5%
N/A-99.9%$16K$11.11M0.00110Gap Up
High Trading Volume
SYRS
Syros Pharmaceuticals
4.099 of 5 stars
$0.02
+471.4%
$3.33
+16,566.7%
-99.8%$537K$386K-0.01120Gap Up
VIRX
Viracta Therapeutics
1.9723 of 5 stars
$0.01
flat
$1.75
+17,793.7%
N/A$389KN/A-0.0120News Coverage
NCNA
NuCana
3.2677 of 5 stars
$0.05
+3.9%
$25.00
+47,069.8%
-98.6%$310KN/A-0.0130Gap Up
High Trading Volume
CAPS
Capstone Therapeutics
N/A$1.60
-1.2%
N/AN/A$260K$44.88M0.0038Positive News
VINC
Vincerx Pharma
2.629 of 5 stars
$0.06
+15.2%
$40.00
+70,075.4%
-99.7%$259KN/A0.0060Gap Down
BON
Bon Natural Life
N/A$1.44
+1.4%
N/A-97.3%$240K$23.84M0.00100
MYMD
MyMD Pharmaceuticals
N/A$0.09
-7.6%
N/A-93.9%$207KN/A0.006Gap Down
High Trading Volume
UPC
Universe Pharmaceuticals
N/A$3.76
+7.9%
N/A-99.8%$161K$19.29M0.00220
VRPX
Virpax Pharmaceuticals
N/A$0.06
-81.9%
N/A-99.8%$74KN/A0.007Gap Down
SCPS
Scopus BioPharma
N/A$0.00
flat
N/AN/A$13KN/A0.009

Related Companies and Tools


This page (NASDAQ:SMFL) was last updated on 7/29/2025 by MarketBeat.com Staff
From Our Partners